Meeting Coverage

ASTRO

American Society for Radiation Oncology

Metastasis-Directed Therapy for Prostate Cancer Increases PFS, Time off Hormones

Radiotherapy led to "dramatic" slowing of progression, increased time with normal testosterone

ASTRO over a photo of Henry B. Gonzalez Convention Center in San Antonio, Texas

Latest ASTRO Meetings

Ablative MR-Guided RT Shows Promise in Pancreatic Cancer

SMART safe in patients with borderline or locally advanced cancer, with encouraging early OS data

October 27, 2022
Concurrent Boost During Hypofractionated RT Proves Its Worth in Early Breast Cancer

Reduces treatment time, noninferior to conventional RT with sequential boost after lumpectomy

October 26, 2022
Radiation for Asymptomatic Bone Metastases May Improve Cancer Survival

Fewer skeletal events, less pain unexpectedly followed by longer life

October 26, 2022
Sexual Health Not Part of Discussion for Women Undergoing Brachytherapy

Much less likely than men to be queried about sexual function when receiving treatment

October 25, 2022
Shorter Course of Radiation Therapy Proves Mettle in High-Risk Prostate Cancer

Hypofractionation matches standard RT for survival and toxicity in a third less time

October 25, 2022
Low Rates of PSA Screening Linked to Increase in Metastatic Prostate Cancer

Will USPSTF's 2018 guidelines reverse this trend?

October 25, 2022
New Standard-of-Care Therapy for Advanced Liver Cancer

Stereotactic body radiotherapy plus sorafenib improves survival versus targeted drug alone

October 24, 2022
Rapid Radiotherapy Technique Shows Promise in First Human Trial

FLASH relieved pain in most patients with bone metastases, with few side effects

October 24, 2022
High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOL

Patients report better urinary and bowel function outcomes

October 24, 2022
Tumor Volume-Adapted RT Leads to Good Lung Cancer Control With Low Toxicity

No recurrence at 1 year in 90% of cases with primary tumors, metastases, synchronous disease

November 2, 2021
Primary RT Fares Well in Abbreviated Trial for HPV Oropharyngeal Cancer

No deaths, progression with RT after early termination because of deaths in surgery arm

October 29, 2021
Mixed Results With RT Plus Short-Term ADT in Intermediate-Risk Prostate Cancer

No survival benefit, but risk of biochemical failure, metastasis, cancer death improved

October 28, 2021
Meta-Analysis Reaffirms Role of ADT With Radiotherapy in Prostate Cancer

Prolonged adjuvant ADT also improved survival

October 27, 2021
Extended-Field RT Boosts Survival in Locally Advanced Cervical Cancer

Double-digit improvements in OS, DFS, extrapelvic control in well-selected patients

October 27, 2021